Menu Close
The Conversation

Articles on Drug regulators

Displaying all articles
In addition to evaluating new drug applications, the FDA also inspects drug manufacturing facilities. The U.S. Food and Drug Administration/Flickr

Challenging the FDA’s authority isn’t new – the agency’s history shows what’s at stake when drug regulation is in limbo

Christine Coughlin, Wake Forest University

As the government’s oldest consumer protection agency, the FDA has long butted up against drugmakers, activists and politicians. But undermining its work could be harmful to patient health and safety.
Despite monitoring the same drugs, Australia, Canada, the United Kingdom and the United States issued the same drug warnings only seven per cent of the time over a 10-year period. (Pixabay)

Drug Safety: Health Canada must act faster when approved medications show risks

Joel Lexchin, University of Toronto

Health Canada devotes far more resources to getting new drugs onto the market compared to making sure that drugs already being sold are safe.
Health Canada is proposing a new system to fast-track urgent drugs for children, the elderly and those with serious or life-threatening conditions. This would rely on decisions made by regulators in other jurisdictions. (Shutterstock)

Should Health Canada rely on foreign assessment of new drugs?

Joel Lexchin, University of Toronto

Health Canada is proposing to allow some prescription drugs into the country with only ‘cursory clinical review.’ Here’s why we should be worried.

Related Topics

  1. AIDS
  2. Anthony Fauci
  3. Diptheria
  4. Drugmakers
  5. Drug regulation
  6. Drug safety
  7. Food and Drug Administration (FDA)
  8. Health Canada
  9. Mifepristone

Top contributors